Alterations in neurotransmitter co-release in Parkinson’s disease

Output Details

Published October 2, 2023

Parkinson's disease is a neurological disorder characterized by degeneration of midbrain dopamine neurons, which results in numerous adaptations in basal ganglia circuits. Research over the past twenty-five years has identified that midbrain dopamine neurons of the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) co-release multiple other transmitters including glutamate and GABA, in addition to their canonical transmitter, dopamine. This review summarizes previous work characterizing neurotransmitter co-release from dopamine neurons, work examining potential changes in co-release dynamics that result in animal models of Parkinson's disease, and future opportunities for determining how dysfunction in co-release may contribute to circuit dysfunction in Parkinson's disease.
Tags
  • Basal Ganglia
  • Dopamine
  • Neural circuitry
  • Neurotransmitters
  • Parkinson's disease
  • Review

Meet the Authors

  • Kelsey Barcomb, PhD

    Key Personnel: Team Edwards

    University of Colorado Anschutz Medical Campus

  • Chris Ford, PhD

    Collaborating PI: Team Edwards

    University of Colorado